Bayer touts glucose meters with Jonas-judged UGC contest

Share this article:
Bayer touts glucose meters with Jonas-judged UGC contest
Bayer touts glucose meters with Jonas-judged UGC contest
Bayer Diabetes Care is plugging its line of glucose meters with a new website and a contest offering kids with diabetes a chance to meet Nick Jonas of the Jonas Brothers.

Kids with diabetes aged 6-18 can enter the Express Your Simple Win Creativity Contest by submitting a 15- 30-second video containing their “song, lyric, story, drawing, photo, movie or other creative idea” about a “simple win,” or “small, everyday victories for managing diabetes.”

Each month since April, “Team Jonas” has selected three semi-finalists from which registered users have voted for a monthly winner, each of whom is required to submit a letter from their physician certifying that they have diabetes. At the end of September, Jonas will select three of them as grand prize winners.  

The site, simplewins.com, offers videos and printable content on diabetes management for kids and adults with type 1 or type 2 diabetes. Visitors can set up email refill reminders and download coupons for test strips.

Bayer makes the Contour, Breeze 2 and A1CNow Selfcheck meters.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...